0 CHECKOUT

PRODUCT FILTERS

REGION

18
4
3
3
3

COUNTRY

PRICE

16
55
90
163

PUBLISHED

3
17
69
163

PRODUCT TYPE

149
8
4
2

Lymphoma Drugs Market Research Reports

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

NHL: Diffuse Large Bcell Lymphoma: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

An increase in disease prevalence and the launch of new targeted therapies across a range of treatment settings will drive the growth of the diffuse large B-cell lymphoma (DLBCL) market during 2016-25...

Published:  May 2016
Price:  From

Nhl: Mantle Cell Lymphoma: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

An increase in incident cases, combined with the expanded use of costly treatments such as Imbruvica and Revlimid, will drive the growth of the mantle cell lymphoma (MCL) market during 2016-25. This...

Published:  April 2016
Price:  From

Nhl: Follicular Lymphoma: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

The follicular lymphoma (FL) market will continue to grow during 2016-25, despite the entry of biosimilars and generics, due to an increase in disease incidence and the launch of new pipeline therapies. This...

Published:  April 2016
Price:  From

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

Immune system consists of various cells that impart resistance to body against foreign entities. They also prevent the development of aberrant cells in the body to maintain its normal functioning. However,...

Published:  March 2016
Price:  From

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing...

Published:  November 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

Summary “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016” report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Lymphoma...

Published:  August 2016
Price:  From

Target Atlas in Lymphoma: A Competitive Outlook

Extra value: One year of free online updates included with this product "Target Atlas in Lymphoma: A Competitive Outlook" helps you to understand the complex world of commercial development in lymphoma...

Published:  August 2016
Price:  From

Lymphoma Drug Pathway Analyzer

Extra value: One year of free online updates included with this product There are today at least 563 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways...

Published:  August 2016
Price:  From

Lymphoma Drug Pipeline Update

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 383 companies plus partners developing 568 lymphoma drugs in 1073 developmental projects in cancer....

Published:  August 2016
Price:  From

Indolent Lymphoma-Pipeline Insights, 2016

“Indolent Lymphoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The Report covers the product profiles in...

Published:  August 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

“Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Large Cell Lymphoma (ALCL)....

Published:  August 2016
Price:  From

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

“Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The Report covers the product...

Published:  August 2016
Price:  From

Lymphoblastic Lymphoma-Pipeline Insights, 2016

“Lymphoblastic Lymphoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. The Report covers the product...

Published:  August 2016
Price:  From

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

“B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. The Report covers the...

Published:  August 2016
Price:  From

Mycosis Fungoides-Pipeline Insights, 2016

“Mycosis Fungoides-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Mycosis Fungoides. The Report covers the product profiles in...

Published:  August 2016
Price:  From

T-Cell Lymphomas-Pipeline Insights, 2016

“T-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the T-Cell Lymphomas. The Report covers the product profiles in...

Published:  August 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

“Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Peripheral T-Cell Lymphomas (PTCL). The Report...

Published:  August 2016
Price:  From

B-Cell Lymphomas-Pipeline Insights, 2016

“B-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the B-Cell Lymphomas. The Report covers the product profiles in...

Published:  August 2016
Price:  From

Waldenstrom Macroglobulinemia-Pipeline Insights, 2016

“Waldenstrom Macroglobulinemia-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Waldenstrom Macroglobulinemia. The Report covers...

Published:  August 2016
Price:  From
Loading Indicator

Our Clients